期刊文献+

PDCD5因子增强顺铂抑制结肠癌细胞生长作用的体内研究 被引量:2

Programmed cell death 5 enhance inhibitory effect of cisplatin on growth of colorec- tal carcinoma cells in vivo
下载PDF
导出
摘要 目的通过体内实验研究稳定转染程序性细胞死亡5(PDCD5)因子的结肠癌细胞对顺铂的敏感性,探讨PDCD5因子与顺铂联合治疗结肠癌的可行性。方法稳定转染PDCD5因子的结肠癌细胞SW480/PDCD5、稳定转染空载体的结肠癌细胞SW480/Neo及正常结肠癌细胞SW480分别接种到裸鼠皮下,形成皮下移植瘤后,顺铂(10 mg/kg)腹腔内注射,绘制移植瘤生长曲线;组织学观察皮下移植瘤,TUNEL法检测皮下移植瘤的凋亡情况;Western印迹法检测皮下移植瘤caspase-9和caspase-3的表达水平。结果 SW480/PDCD5对顺铂更加敏感,肿瘤体积增加幅度低于SW480和SW480/Neo(P<0.05);SW480/PDCD5有更多的细胞出现变性坏死,更多的细胞染色体边集并出现凋亡小体,出现凋亡细胞的比例高于SW480和SW480/Neo(P<0.05);SW480/PDCD5中caspase-9和caspase-3的活化片段较SW480和SW480/Neo更多(P<0.05)。结论稳定转染PDCD5因子可以增加结肠癌细胞对顺铂的敏感性,二者联合应用在结肠癌治疗中有潜在的价值。 Objective To investigate the inhibitory effects of Programmed cell death 5 (PDCD5) in combination with cisplatin on colorectal carcinoma cells in vivo. Methods Colorectal cancer cells of SW480, SW480/Neo and SW480/PDCD5 were subcutaneously inoculated into the nude mice, and cisplatin (10 mg/kg) was administrated via in- traperitoneal injection. Histologic apoptosis analysis and tumor growth curves of colorectal cancer xenografl model were accomplished. Caspase-9 and caspase-3 were determined by Western blotting. Results Compared with SW480 and SW480/Neo, SW480/PDCD5 was more sensitive to cisplatin, and its tumor volume increased smaller (P 〈 0.05). Combination of PDCD5 and cisplatin caused obviously cell death in tumor mass via apoptosis (P 〈 0.05 ). Compared with SW480 and SW480/Neo, SW480/PDCD5 showed more cleaved caspase-9 and caspase-3 (P 〈 0.05). Conclusion Stable overexpression of PDCD5 increases sensitivity of the cells to cisplatin, PDCD5 therapy in combination with cis- platin could be promising alternative in colorectal cancer treatment.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第1期22-25,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 程序性细胞死亡5因子 顺铂 结肠癌移植瘤模型 Programmed cell death 5 (PDCDS) Cisplatin Colorectal cancer xenograft model
  • 相关文献

参考文献18

  • 1Galluzzi L,Senovilla L,Vitale I. Molecular mechanisms of cisplatin resistance[J].{H}ONCOGENE,2012,(15):1869-1883.
  • 2Wang D,Lippard SJ. Cellular processing of platinum anticancer drugs[J].{H}Nature Reviews Drug Discovery,2005,(04):307-320.
  • 3Liu H,Wang Y,Zhang Y. TFAR19,a novel apoptosis-related gene cloned from human leukemia cell line TF-1,could enhance apoptosis of some tumor cells induced by growth factor withdrawal[J].{H}Biochemical and Biophysical Research Communications,1999,(01):203-210.
  • 4印安宁,江应安,罗和生.程序性细胞死亡5因子增强顺铂抑制结肠癌细胞生长作用的体外研究[J].胃肠病学和肝病学杂志,2013,22(5):413-416. 被引量:1
  • 5Yin A,Jiang Y,Zhang X. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo[J].{H}EUROPEAN JOURNAL OF PHARMACOLOGY,2010,(1-3):120-126.
  • 6Kauffman GB,Pentimalli R,Doldi S. Michele Peyrone (1813-1883),Discoverer of Cisplatin[J].{H}Platinum Metals Review,2010,(04):250-256.
  • 7Rosenberg B,Van Camp L,Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode[J].{H}NATURE,1965,(4972):698-699.
  • 8Omura K. Advances in chemotherapy against advanced or metastatic colorectal cancer[J].{H}DIGESTION,2008,(Suppl 1):13-22.
  • 9Tol J,Koopman M,Cats A. Chemotherapy,bevacizumab,and cetuximab in metastatic colorectal cancer[J].{H}New England Journal of Medicine,2009,(06):563-572.
  • 10K(o)hne CH,Lenz HJ. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer[J].{H}Oncologist(the)t,2009,(05):478-488.

二级参考文献12

  • 1GaUuzzi L, Senovilla L, Vitale I, ct ul. Molecular mechanisms of cis-platin resistance[J]. Oncogene, 2012. 31 (15): 1869-1883.
  • 2Liu H, Wang ¥, Zhang ¥, et al. TFARI9, a novel apoptosis-related gene cloned from human leukemia cell line TF-I , could enhance apop-tosis of some tumor cells induced by growth factor withdrawal[J]. Bio-chern Biophys Res Commun, 1999,254(1): 203-210.
  • 3Yin A,Jiang ¥, Zhang X, et al. Transfection of PDCD5 sensitizes color-ectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo[J]. EurJ Pharmacol, 2010, 649 ( \ -3): 120-\26.
  • 4Oyama K, Shiota G. lto H, et al. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats[J]. Carcinogenesis, 2002, 23 (5) : 885-892.
  • 5Wang 0, Lippard SJ. Cellular processing of platinum anticancer drugs[J]. Nat Hev Drug Discov, 200S. 4 (4) : 307 -320.
  • 6Omura K. Advances in chemotherapy against advanced or metastatic colorectal cancer[J]. Digestion, 2008, 77 Suppl I : 13-22.
  • 7TolJ, Koopman M, Cats A. et al. Chemotherapy, bevar-izumab , and cetuximab in metastatic colorcctal cancer[J]. N EnglJ Med, 2009, 360(6): 563-S72.
  • 8Kohne CH, Lenz HJ. Chemotherapy with targeted agents for the treat-ment of metastatic colorectal cancer[J]. Oncologist, 2009, 14 ( 5 ) : 478-488.
  • 9HongJ, ZhangJ, Liu Z, et 01. Solution structure of S. Cerevisiae PD-CDS-like protein and its promoting role in H (2) 0 (2) -induced apopto-sis in yeast[J]. Biochemistry, 2009, 48(29): 6824-6834.
  • 10Chen C. Zhou H. Xu L, et "I. Recombinant human PDCDS sensitizes chondrosarcomas to cisplaiin chemotherapy in vitro and in vivo (j 1. Apoptosis , 2010, 15(7): 805-813.

同被引文献12

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部